Has Stride Found the Formula for a Sustainable School Choice? — Positive

LRN   Zacks Investment Research — October 15, 2025

Stride, Inc.'s LRN main focus lies in offering online and hybrid education models that align with the growing demand for flexibility, accessibility and personalized learning. In the current education market, students and parents are actively shifting toward virtual education alternatives, AI-based solutions and more career-focused programs.

image for news Has Stride Found the Formula for a Sustainable School Choice?

Prologis Q3 FFO Beats Estimates, Rental Revenues Rise Y/Y — Positive

PLD   Zacks Investment Research — October 15, 2025

PLD's Q3 FFO beats estimates, benefiting from a rise in rental revenues and healthy leasing activity. However, high interest expenses are a concern.

image for news Prologis Q3 FFO Beats Estimates, Rental Revenues Rise Y/Y

After Record Q3 Deliveries, Can Tesla Deliver an Earnings Beat? — Positive

TSLA   Zacks Investment Research — October 15, 2025

After record Q3 deliveries that exceeded expectations, TSLA looks poised to post upbeat third-quarter 2025 results.

image for news After Record Q3 Deliveries, Can Tesla Deliver an Earnings Beat?

3 More Hot Tech Stocks With Bullish Charts and Ample Upside — Positive

AMD  QUBT  SMCI   MarketBeat — October 15, 2025

The technology sector continues to show strength, driven by accelerating AI adoption, capital inflows, and renewed investor confidence. Several stocks are emerging with bullish chart patterns and active catalysts, pointing to the potential for triple-digit gains in the near term.

image for news 3 More Hot Tech Stocks With Bullish Charts and Ample Upside

Merck's New HIV Treatment Works As Well As Top Drug In Late Trials — Positive

MRK   Benzinga — October 15, 2025

The relentless pursuit of innovative treatments in the pharmaceutical industry continues to reshape the landscape of chronic disease management. Merck & Co. Inc. (NYSE:MRK) on Wednesday announced additional data from two Phase 3 studies of a two-drug regimen of doravirine/islatravir (DOR/ISL) in adults with virologically suppressed HIV-1 infection.

image for news Merck's New HIV Treatment Works As Well As Top Drug In Late Trials

Eli Lilly: Outstanding Orforglipron Data Reinforces Value Proposition — Positive

LLY   Seeking Alpha — October 15, 2025

Eli Lilly and Company reported strong Phase 3 results for its oral GLP-1 drug orforglipron in type 2 diabetes, meeting all primary and secondary endpoints. LLY's GLP-1 franchise, including Mounjaro, Zepbound, and orforglipron, underpins its $800bn valuation and continued bullish long-term growth outlook. Despite high valuation and industry headwinds, LLY's management, product pipeline, and market dominance support a 20% upside potential over 18-24 months.

image for news Eli Lilly: Outstanding Orforglipron Data Reinforces Value Proposition

CENTENNIAL, CO / ACCESS Newswire / October 15, 2025 / NioCorp Developments Ltd. ("NioCorp" or the "Company") (Nasdaq:NB) today announced the closing of its previously announced registered direct offering in the United States priced at-the-market in accordance with the rules of The Nasdaq Stock Market LLC (the "Offering").

image for news NioCorp Announces Closing of $150.2 Million Registered Direct Offering of Common Shares Priced At-the-Market

Pony.AI and WeRide have received a key approval from Chinese securities regulators that clears the way for the for the autonomous vehicle technology companies to pursue secondary listings on the Stock Exchange of Hong Kong.

image for news Self-driving car companies Pony.ai and WeRide get the OK for Hong Kong listing

Intel Introduces Leading Edge Data Center GPU: Will it Boost Prospect? — Positive

INTC   Zacks Investment Research — October 15, 2025

INTC's new Crescent Island GPU targets surging AI inference demand with cost-efficient, high-memory performance for enterprise data centers.

image for news Intel Introduces Leading Edge Data Center GPU: Will it Boost Prospect?

Is Boeing in the Crossfire Amid Intensified US-China Trade War? — Negative

BA   Zacks Investment Research — October 15, 2025

BA stock faces fresh turbulence as Trump's export control threat deepens U.S.-China trade tensions, putting its China deals and deliveries at risk.

image for news Is Boeing in the Crossfire Amid Intensified US-China Trade War?

Are Green ETFs in the Crosshairs? Navigating the Rare Earth Supply Shock — Positive

PBW   Zacks Investment Research — October 15, 2025

China's rare earth export curbs threaten the clean energy supply chain, but global exposure helps ETFs like PBW, FRNW, and ICLN stay resilient.

image for news Are Green ETFs in the Crosshairs? Navigating the Rare Earth Supply Shock

TeraWulf: High-Impact Business Pivot — Positive

WULF   Seeking Alpha — October 15, 2025

TeraWulf is rapidly transitioning into a high-performance computing Data Center provider, benefiting from surging AI-driven CapEx investments. WULF's landmark deal with Fluidstack in August, backed by Google, significantly boosts its revenue backlog and cements its role with Tier 1 hyperscalers. The total value (based off of contracted value) of the Fluidstack deal now sits at $6.7B, following an option exercise shortly after the initial deal.

image for news TeraWulf: High-Impact Business Pivot

Bank of America, Morgan Stanley Earnings Prop Up Wall Street — Positive

BAC  MS   Schaeffers Research — October 15, 2025

Bank stocks are setting the tone this week, with a slew of upbeat post-earnings reactions propping up Wall Street.

image for news Bank of America, Morgan Stanley Earnings Prop Up Wall Street

Johnson & Johnson Stock Can Keep Rising as Strategy Pays Off — Neutral

JNJ   MarketBeat — October 15, 2025

Johnson & Johnson's NYSE: JNJ stock price can continue to advance because its strategy to reinvigorate growth and widen margins is working. The plan centers on divesting underperforming healthcare businesses to focus on higher-margin, more potent growth markets.

image for news Johnson & Johnson Stock Can Keep Rising as Strategy Pays Off

Copper ETF (COPJ) Hits New 52-Week High — Positive

COPJ   Zacks Investment Research — October 15, 2025

COPJ surges to a 52-week high, fueled by copper price gains and optimism over U.S. rate cuts boosting the metal's outlook.

image for news Copper ETF (COPJ) Hits New 52-Week High

Estee Lauder Launches Paris Fragrance Atelier to Drive Innovation — Neutral

EL   Zacks Investment Research — October 15, 2025

EL opens a Paris Fragrance Atelier blending AI, neuroscience and artistry to reinvent luxury perfume creation.

image for news Estee Lauder Launches Paris Fragrance Atelier to Drive Innovation

BELMONT, Calif.--(BUSINESS WIRE)--The Mobility House, a global leader in smart charging and energy management solutions, and Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, are beginning a groundbreaking project in New York State to implement technology to accelerate fleet electrification. This initiative, supported by the New York State Energy Research and Development Authority (NYSERDA), will use cutting-edge flexible service conne.

image for news The Mobility House and Itron to Demonstrate Pioneering Fleet Electrification Technology for Utilities

Walmart's U.S. head said shoppers were spending at a healthy rate and were resilient despite economic uncertainty and inflationary prices due to President Donald Trump's tariffs, Bloomberg News reported on Wednesday.

image for news Walmart US CEO says shoppers still spending at a healthy rate, Bloomberg News reports

Could Silver Hit $100? These 3 Standout Stocks Are Set to Strike It Rich — Positive

AG  SLV  WPM   24/7 Wall Street — October 15, 2025

image for news Could Silver Hit $100? These 3 Standout Stocks Are Set to Strike It Rich

Netskope: A Cybersecurity IPO Worth Knowing — Positive

NTSK   Seeking Alpha — October 15, 2025

Netskope, Inc. is a market leader in CASB and SASE, and it has been achieving strong revenue growth and expanding its enterprise customer base. NTSK's deep cloud visibility, AI-driven security, and proprietary NewEdge network provide performance and security advantages over competitors like Zscaler and Palo Alto. While not yet profitable, NTSK is rapidly improving margins, demonstrating disciplined cost control and a clear path to positive free cash flow.

image for news Netskope: A Cybersecurity IPO Worth Knowing